Chelator boosted tumor-retention and pharmacokinetic properties: development of 64 Cu labeled radiopharmaceuticals targeting neurotensin receptor.
Tao ZhangXinrui MaMuyun XuJinghua CaiJianhua CaiYanguang CaoZhihao ZhangXin JiJian HeGerman Oscar Fonseca CabreraXuedan WuWeiling ZhaoZhanhong WuJin XieZibo LiPublished in: European journal of nuclear medicine and molecular imaging (2024)
Cu.